Combined treatment with systemic resveratrol and resveratrol preconditioned mesenchymal stem cells, maximizes antifibrotic action in diabetic cardiomyopathy.

ShamsEldeen, Asmaa Mohammed

Combined treatment with systemic resveratrol and resveratrol preconditioned mesenchymal stem cells, maximizes antifibrotic action in diabetic cardiomyopathy. [electronic resource] - Journal of cellular physiology 07 2019 - 10942-10963 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1097-4652

10.1002/jcp.27947 doi


Animals
Antioxidants--therapeutic use
Bone Malalignment
Diabetes Mellitus, Experimental--complications
Diabetic Cardiomyopathies--therapy
Fibrosis--therapy
Male
Mesenchymal Stem Cell Transplantation
Mesenchymal Stem Cells--drug effects
Random Allocation
Rats
Rats, Wistar
Resveratrol--therapeutic use